V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280004878 | 280003256 | 1.74 | 69.8 | Curative (C) | 2017-08-17 | 2017-09-01 | Carboplatin AUC 2 - 5 | 02 | N | 280028105 | CARBOPLATIN |
| 280004879 | 280003256 | 1.8 | 83.1 | Curative (C) | null | 2014-01-22 | Carboplatin + Etoposide IV 3 day | null | null | 280028105 | CARBOPLATIN + ETOPOSIDE |
| 280004880 | 280003256 | null | 47.6 | Neo-adjuvant (N) | 2013-03-14 | 2013-04-03 | Cetuximab 7 day (Cycle 1) | N | N | 280028105 | CETUXIMAB |
| 280004881 | 280003257 | 1.63 | 52 | Neo-adjuvant (N) | 2017-02-01 | 2017-02-22 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 280028113 | CISPLATIN + GEMCITABINE |
| 280004882 | 280007673 | 1.95 | 51.5 | Not known (9) | 2016-06-16 | 2016-06-25 | Trial Unspecified | N | null | 280028114 | TRIAL |
| 280004883 | 280003258 | null | 90 | null | 2017-09-21 | 2017-10-17 | CARBOPLATIN + RT | 2 | N | 280028118 | CARBOPLATIN + RT |
| 280004884 | 280007674 | 1.85 | 84 | Palliative (P) | 2014-06-07 | 2014-06-18 | Carboplatin + Paclitaxel (3 weekly) | N | Y | 280028119 | CARBOPLATIN + PACLITAXEL |
| 280004885 | 280007674 | 1.78 | 81.6 | Palliative (P) | 2014-07-28 | 2014-08-01 | CISPLATIN + GEMCITABINE | 02 | Y | 280028119 | CISPLATIN + GEMCITABINE |
| 280004886 | 280003259 | null | 68 | Adjuvant (A) | 2015-09-27 | 2015-09-28 | Cisplatin+Gemcitabine (gallbladder) | null | null | 280028123 | CISPLATIN + GEMCITABINE |
| 280004887 | 280003259 | null | 110 | null | null | 2016-08-11 | CARBOPLATIN + RT | N | null | 280028123 | CARBOPLATIN + RT |
| 280004888 | 280003259 | 1.73 | 68.7 | Curative (C) | 2017-01-15 | 2017-01-15 | CISPLATIN + GEMCITABINE | Y | N | 280028123 | CISPLATIN + GEMCITABINE |
| 280004889 | 280003259 | null | null | Palliative (P) | 2016-09-15 | 2016-09-15 | WT SIOP 2002 01 post op Carbo, Etop | 2 | N | 280028123 | NOT MATCHED |
| 280004890 | 280003260 | null | 77.9 | Curative (C) | 2013-12-31 | 2013-12-31 | CARBOPLATIN + RT | N | null | 280028133 | CARBOPLATIN + RT |
| 280004891 | 280003260 | null | 63 | null | 2016-01-08 | 2016-01-08 | CARBOPLATIN + ETOPOSIDE | N | Y | 280028133 | CARBOPLATIN + ETOPOSIDE |
| 280004892 | 280003261 | 1.61 | 57 | Curative (C) | 2013-04-12 | 2013-04-20 | Carboplatin + Etoposide iv&po | N | N | 280028141 | CARBOPLATIN + ETOPOSIDE |
| 280004893 | 280003261 | null | 69.4 | Curative (C) | 2017-02-04 | 2017-03-05 | CETUXIMAB | 02 | Y | 280028141 | CETUXIMAB |
| 280004894 | 280003261 | 1.7 | 76.9 | Neo-adjuvant (N) | 2015-06-10 | 2015-06-11 | CARBOPLATIN + ETOPOSIDE | Y | N | 280028141 | CARBOPLATIN + ETOPOSIDE |
| 280004895 | 280003261 | 1.6 | 9.5 | Curative (C) | 2015-02-28 | 2015-03-04 | EW EuroEwing 2012 Arm A VAC | N | N | 280028141 | NOT MATCHED |
| 280004896 | 280003262 | 1.79 | 69.9 | Curative (C) | 2015-09-26 | 2015-10-16 | Cetuximab 7 day (Cycle 1) | 2 | N | 280028150 | CETUXIMAB |
| 280004897 | 280007678 | 1.71 | 80.9 | Curative (C) | 2016-05-19 | 2016-06-19 | Carboplatin AUC 2 - 5 | N | Y | 280028151 | CARBOPLATIN |
| 280004898 | 280003263 | 1.8 | 86.3 | Curative (C) | 2017-09-04 | 2017-09-05 | Carboplatin AUC 2 - 5 | null | null | 280028152 | CARBOPLATIN |
| 280004899 | 280007679 | null | null | Curative (C) | 2016-07-02 | 2016-07-19 | Cetuximab 7 day (Cycle 1) | N | Y | 280028158 | CETUXIMAB |
| 280004900 | 280009916 | 1.58 | 46.8 | Curative (C) | 2013-06-10 | 2013-06-17 | Carboplatin + Etoposide iv&po | N | N | 280028159 | CARBOPLATIN + ETOPOSIDE |
| 280004901 | 280003264 | 1.85 | 68 | Curative (C) | 2016-03-11 | 2016-03-24 | Carboplatin + Paclitaxel (3 weekly) | N | Y | 280028160 | CARBOPLATIN + PACLITAXEL |
| 280004902 | 280003264 | 1.66 | 43.85 | null | 2017-11-21 | 2017-11-29 | CARBOPLATIN + ETOPOSIDE | null | null | 280028160 | CARBOPLATIN + ETOPOSIDE |
| 280004903 | 280003265 | 1.68 | 19.4 | null | 2015-03-21 | 2015-03-21 | Cetuximab 7 day (Cycle 1) | 02 | N | 280028165 | CETUXIMAB |
| 280004904 | 280007681 | 1.74 | 75.1 | Adjuvant (A) | 2016-09-08 | 2016-09-28 | Carboplatin AUC 6 - 10 | N | N | 280028167 | CARBOPLATIN |
| 280004905 | 280003266 | 1.58 | null | Curative (C) | 2016-06-07 | 2016-06-19 | Cisplatin+Gemcitabine (gallbladder) | N | N | 280028168 | CISPLATIN + GEMCITABINE |
| 280004906 | 280003266 | null | 86.7 | Palliative (P) | 2014-03-21 | 2014-03-25 | CETUXIMAB | N | N | 280028168 | CETUXIMAB |
| 280004907 | 280009917 | 1.66 | 31.1 | null | 2017-05-13 | 2017-05-17 | Trial Unspecified | N | Y | 280028170 | TRIAL |
| 280004908 | 280009917 | null | null | Curative (C) | null | 2017-05-09 | Carboplatin + Etoposide IV 3 day | 02 | N | 280028170 | CARBOPLATIN + ETOPOSIDE |
| 280004909 | 280003267 | null | 84.4 | Palliative (P) | 2013-10-11 | 2013-10-28 | Carboplatin + Etoposide iv&po | N | Y | 280028172 | CARBOPLATIN + ETOPOSIDE |
| 280004910 | 280003267 | 1.77 | 102 | Curative (C) | 2013-01-30 | 2013-02-16 | CISPLATIN + GEMCITABINE | 02 | N | 280028172 | CISPLATIN + GEMCITABINE |
| 280004911 | 280003268 | 1.62 | 78.1 | Palliative (P) | 2018-01-22 | 2018-01-26 | Trial Unspecified | 02 | N | 280028178 | TRIAL |
| 280004912 | 280007684 | 1.64 | 83.15 | Palliative (P) | 2014-04-15 | 2014-04-28 | CETUXIMAB | 02 | Y | 280028179 | CETUXIMAB |
| 280004913 | 280003269 | null | 80.9 | Neo-adjuvant (N) | 2017-03-22 | 2017-03-22 | STS Non-Rhabdo EpSSG 2005 VBL/MTX | N | N | 280028180 | NOT MATCHED |
| 280004914 | 280003269 | null | 81 | Curative (C) | 2014-11-09 | 2014-11-16 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | Y | 280028180 | NOT MATCHED |
| 280004915 | 280003270 | 0 | null | Palliative (P) | 2014-05-25 | 2014-05-29 | NB Low/Interm risk guidelines Carbo/Etop | N | Y | 280028182 | NOT MATCHED |
| 280004916 | 280003270 | 1.79 | 12.8 | Curative (C) | 2014-10-28 | 2014-11-04 | CETUXIMAB | N | N | 280028182 | CETUXIMAB |
| 280004917 | 280003270 | 1.8 | 69.6 | Palliative (P) | 2017-11-27 | 2017-11-27 | Cisplatin+Gemcitabine (gallbladder) | N | Y | 280028182 | CISPLATIN + GEMCITABINE |
| 280004918 | 280003270 | null | 107 | Curative (C) | 2018-01-24 | 2018-01-24 | Carboplatin AUC 6 - 10 | 2 | N | 280028182 | CARBOPLATIN |
| 280004919 | 280003271 | 1.56 | 54 | null | 2013-03-24 | 2013-04-07 | EOX | N | N | 280028186 | EOX |
| 280004920 | 280007687 | 0 | 110 | Curative (C) | 2013-07-31 | 2013-07-31 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | Y | 280028189 | NOT MATCHED |
| 280004921 | 280007687 | 1.62 | 58.8 | Curative (C) | 2013-09-03 | 2013-09-03 | EOX | N | N | 280028189 | EOX |
| 280004922 | 280007687 | 1.17 | 87.25 | Palliative (P) | 2017-02-27 | 2017-03-26 | Trial Unspecified | N | Y | 280028189 | TRIAL |
| 280004923 | 280007687 | 1.8 | 104.6 | Not known (9) | 2017-01-30 | 2017-02-28 | Carboplatin AUC 2 - 5 | null | Y | 280028189 | CARBOPLATIN |
| 280004924 | 280003272 | 1.77 | 51.5 | Curative (C) | 2016-05-18 | 2016-05-18 | CARBOPLATIN + RT | N | Y | 280028196 | CARBOPLATIN + RT |
| 280004925 | 280003272 | 1.63 | 53 | Curative (C) | null | 2016-10-07 | Carboplatin + Etoposide iv&po | null | null | 280028196 | CARBOPLATIN + ETOPOSIDE |
| 280004926 | 280009920 | 1.75 | 101.6 | Curative (C) | 2013-09-07 | 2013-10-05 | CARBOPLATIN + RT | 2 | N | 280028198 | CARBOPLATIN + RT |
| 280004927 | 280003273 | 1.8 | 30 | Curative (C) | null | 2017-10-17 | Carboplatin + Paclitaxel (3 weekly) | null | null | 280028199 | CARBOPLATIN + PACLITAXEL |